Cornell Pochily Investment Advisors, Inc. Gilead Sciences, Inc. Transaction History

Cornell Pochily Investment Advisors, Inc.

$252 Million
Q1 2024

A detailed history of Cornell Pochily Investment Advisors, Inc. transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Cornell Pochily Investment Advisors, Inc. holds 11,539 shares of GILD stock, worth $779,459. This represents 0.33% of its overall portfolio holdings.

Number of Shares

11,539

Previous 14,708 21.55%

Holding current value

$779,459

Previous $1.19 Million 29.05%

% of portfolio

0.33%

Previous 0.49%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 23, 2024	SELL	$71.58 - $87.29 $226,837 - $276,622	-3,169 Reduced 21.55%	11,539 $845,000
Q4 2023 Jan 18, 2024	BUY	$73.27 - $83.09 $120,309 - $136,433	1,642 Added 12.57%	14,708 $1.19 Million
Q3 2023 Oct 13, 2023	BUY	$73.94 - $80.67 $14,270 - $15,569	193 Added 1.5%	13,066 $979,000
Q2 2023 Jul 20, 2023	BUY	$76.01 - $86.7 $7,905 - $9,016	104 Added 0.81%	12,873 $992,000
Q1 2023 Apr 17, 2023	SELL	$77.31 - $88.08 $3,556 - $4,051	-46 Reduced 0.36%	12,769 $1.06 Million

Q4 2022 Feb 01, 2023	SELL	$62.32 - $89.47 $22,871 - $32,835	-367 Reduced 2.78%	12,815 $1.1 Million
Q3 2022 Oct 12, 2022	BUY	$59.54 - $68.01 $373,077 - $426,150	6,266 Added 90.6%	13,182 $813,000
Q2 2022 Jul 20, 2022	BUY	$57.72 - $65.01 $20,894 - $23,533	362 Added 5.52%	6,916 $428,000
Q1 2022 Apr 29, 2022	BUY	$57.92 - $72.58 $20,329 - $25,475	351 Added 5.66%	6,554 $390,000
Q4 2021 Jan 19, 2022	BUY	$64.88 - $73.64 $13,040 - $14,801	201 Added 3.35%	6,203 $450,000
Q3 2021 Oct 21, 2021	BUY	$67.69 - $73.03 $67 - $73	1 Added 0.02%	6,002 $419,000
Q2 2021 Jul 23, 2021	BUY	$63.47 - $69.35 $11,170 - $12,205	176 Added 3.02%	6,001 $413,000
Q1 2021 Apr 22, 2021	BUY	$60.0 - $68.46 $106,260 - $121,242	1,771 Added 43.69%	5,825 $376,000
Q4 2020 Feb 01, 2021	BUY	$56.65 - $64.55 $56 - $64	1 Added 0.02%	4,054 $236,000
Q3 2020 Oct 14, 2020	BUY	$62.1 - $78.08 $62 - $78	1 Added 0.02%	4,053 $256,000
Q2 2020 Jul 24, 2020	SELL	$72.34 - $84.0 $243,424 - $282,660	-3,365 Reduced 45.37%	4,052 $312,000
Q1 2020 Apr 16, 2020	SELL	$62.63 - $80.22 $115,928 - $148,487	-1,851 Reduced 19.97%	7,417 $555,000
Q3 2019 Nov 08, 2019	SELL	$62.51 - $69.0 $44,944 - $49,611	-719 Reduced 7.2%	9,268 $587,000
Q2 2019 Jul 22, 2019	SELL	$61.87 - $69.38 $5,815 - $6,521	-94 Reduced 0.93%	9,987 $675,000
Q1 2019 Apr 19, 2019	SELL	$62.53 - $70.05 $3,063 - $3,432	-49 Reduced 0.48%	10,081 $655,000
Q4 2018 Feb 06, 2019	BUY	$60.54 - $79.0 $4,601 - $6,004	76 Added 0.76%	10,130 $633,000
Q3 2018 Oct 26, 2018	BUY	$71.28 - $78.92 $71 - $78	1 Added 0.01%	10,054 $776,000
Q2 2018 Aug 03, 2018	SELL	$64.88 - $75.68 $8,045 - $9,384	-124 Reduced 1.22%	10,053 $712,000
Q1 2018 Apr 25, 2018	SELL	$72.84 - $88.8 $3,642 - $4,440	-50 Reduced 0.49%	10,177 $767,000
Q4 2017 Apr 05, 2018	BUY	$71.15 - $83.52 $727,651 - $854,159	10,227	10,227 $732,000

Others Institutions Holding GILD

# of Institutions

1,885

Shares Held

Call Options Held

8.71M

Put Options Held

8.02M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $84.7B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cornell Pochily Investment Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Cornell Pochily Investment Advisors, Inc. with notifications on news.

Account

Cornell Pochily Investment Advisors, Inc. Gilead Sciences, Inc. Transaction History